Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction

NCT03359863 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Restrictive Chronic Lung Allograft Dysfunction
Lung Transplant Rejection

Interventions

DRUG: Pirfenidone

Sponsor

University of California, San Francisco

Collaborators

[object Object]